ERIS Lifesciences Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Mar'2025 | Mar'2024 | Mar'2023 | Mar'2022 | Mar'2021 | |
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 13.62 | 13.60 | 13.60 | 13.59 | 13.58 |
Reserves | 2,501.28 | 2,510.42 | 2,208.29 | 1,904.51 | 1,561.89 |
Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Application Money | 0.00 | 0.00 | 0.00 | 0.45 | 0.00 |
Total Shareholders Funds | 2,514.90 | 2,524.02 | 2,221.89 | 1,918.55 | 1,575.47 |
Secured Loans | 820.45 | 2,432.84 | 316.87 | 0.00 | 0.00 |
Unsecured Loans | 1,424.42 | 139.14 | 0.00 | 0.00 | 0.00 |
Total Debt | 2,244.87 | 2,571.98 | 316.87 | 0.00 | 0.00 |
Other Liabilities | 58.94 | 42.80 | 68.53 | 65.62 | 34.88 |
Total Liabilities | 4,818.71 | 5,138.80 | 2,607.29 | 1,984.17 | 1,610.35 |
APPLICATION OF FUNDS : | |||||
Gross Block | 2,875.21 | 1,811.21 | 1,094.83 | 778.40 | 716.88 |
Less: Accumulated Depreciation | 463.03 | 295.65 | 197.02 | 136.40 | 132.55 |
Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Block | 2,412.18 | 1,515.56 | 897.81 | 642.00 | 584.33 |
Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Work in Progress | 0.27 | 0.61 | 0.34 | 2.98 | 1.56 |
Investments | 991.27 | 1,618.95 | 996.52 | 777.72 | 531.37 |
Current Assets, Loans & Advances | |||||
Inventories | 191.25 | 91.63 | 63.70 | 84.79 | 64.85 |
Sundry Debtors | 236.19 | 239.97 | 229.22 | 137.56 | 113.76 |
Cash and Bank Balance | 92.46 | 1,296.73 | 47.65 | 46.11 | 32.66 |
Loans and Advances | 107.64 | 248.21 | 181.50 | 212.02 | 161.98 |
Total Current Assets | 627.54 | 1,876.54 | 522.07 | 480.47 | 373.24 |
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 358.80 | 168.08 | 114.10 | 123.38 | 110.08 |
Provisions | 44.92 | 42.69 | 62.27 | 42.86 | 34.38 |
Total CL & Provisions | 403.72 | 210.77 | 176.37 | 166.24 | 144.46 |
Net Current Assets | 223.82 | 1,665.77 | 345.70 | 314.23 | 228.78 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | 576.71 | 485.09 | 399.14 | 350.70 | 297.27 |
Deferred Tax Liability | 293.35 | 181.30 | 125.36 | 114.59 | 100.52 |
Net Deferred Tax | 283.36 | 303.79 | 273.78 | 236.11 | 196.75 |
Other Assets | 907.81 | 34.12 | 93.13 | 11.14 | 67.58 |
Total Assets | 4,818.71 | 5,138.80 | 2,607.29 | 1,984.19 | 1,610.36 |
Contingent Liabilities | 584.54 | 332.46 | 630.39 | 629.34 | 18.32 |